Found: 60
Select item for more details and to access through your institution.
New Antibiotics for Resistant Infections: What Happens After Approval?
- Published in:
- Annals of Internal Medicine, 2024, v. 177, n. 5, p. 674, doi. 10.7326/M24-0192
- By:
- Publication type:
- Article
Moving Beyond Mortality: Development and Application of a Desirability of Outcome Ranking (DOOR) Endpoint for Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia.
- Published in:
- Clinical Infectious Diseases, 2024, v. 78, n. 2, p. 259, doi. 10.1093/cid/ciad576
- By:
- Publication type:
- Article
Priorities and Progress in Gram-positive Bacterial Infection Research by the Antibacterial Resistance Leadership Group: A Narrative Review.
- Published in:
- Clinical Infectious Diseases, 2023, v. 77, p. S295, doi. 10.1093/cid/ciad565
- By:
- Publication type:
- Article
The Future Ain't What It Used to Be...Out With the Old...In With the Better: Antibacterial Resistance Leadership Group Innovations.
- Published in:
- Clinical Infectious Diseases, 2023, v. 77, p. S321, doi. 10.1093/cid/ciad538
- By:
- Publication type:
- Article
Exploration of a Potential Desirability of Outcome Ranking Endpoint for Complicated Intra-Abdominal Infections Using 9 Registrational Trials for Antibacterial Drugs.
- Published in:
- Clinical Infectious Diseases, 2023, v. 77, n. 4, p. 649, doi. 10.1093/cid/ciad239
- By:
- Publication type:
- Article
Improving Traditional Registrational Trial End Points: Development and Application of a Desirability of Outcome Ranking End Point for Complicated Urinary Tract Infection Clinical Trials.
- Published in:
- Clinical Infectious Diseases, 2023, v. 76, n. 3, p. e1157, doi. 10.1093/cid/ciac692
- By:
- Publication type:
- Article
Characterization of a Novel Pathogen in Immunocompromised Patients: Elizabethkingia anophelis—Exploring the Scope of Resistance to Contemporary Antimicrobial Agents and β-lactamase Inhibitors.
- Published in:
- Open Forum Infectious Diseases, 2023, v. 10, n. 2, p. 1, doi. 10.1093/ofid/ofad014
- By:
- Publication type:
- Article
Sulopenem or Ciprofloxacin for the Treatment of Uncomplicated Urinary Tract Infections in Women: A Phase 3, Randomized Trial.
- Published in:
- Clinical Infectious Diseases, 2023, v. 76, n. 1, p. 66, doi. 10.1093/cid/ciac738
- By:
- Publication type:
- Article
Desirability of Outcome Ranking Analysis of a Randomized Clinical Trial Comparing Seven Versus Fourteen Days of Antibiotics for Uncomplicated Gram-Negative Bloodstream Infection.
- Published in:
- Open Forum Infectious Diseases, 2022, v. 9, n. 6, p. 1, doi. 10.1093/ofid/ofac140
- By:
- Publication type:
- Article
Randomized, Double-blind, Multicenter Trial Comparing Efficacy and Safety of Imipenem/Cilastatin/Relebactam Versus Piperacillin/Tazobactam in Adults With Hospital-acquired or Ventilator-associated Bacterial Pneumonia (RESTORE-IMI 2 Study).
- Published in:
- Clinical Infectious Diseases, 2021, v. 73, n. 11, p. e4539, doi. 10.1093/cid/ciaa803
- By:
- Publication type:
- Article
Antibiotic resistance in the patient with cancer: Escalating challenges and paths forward.
- Published in:
- CA: A Cancer Journal for Clinicians, 2021, v. 71, n. 6, p. 488, doi. 10.3322/caac.21697
- By:
- Publication type:
- Article
Antibacterial Resistance Leadership Group 2.0: Back to Business.
- Published in:
- Clinical Infectious Diseases, 2021, v. 73, n. 4, p. 730, doi. 10.1093/cid/ciab141
- By:
- Publication type:
- Article
Factors associated with neutropenia post heart transplantation.
- Published in:
- Transplant Infectious Disease, 2021, v. 23, n. 4, p. 1, doi. 10.1111/tid.13634
- By:
- Publication type:
- Article
Antibiotic Development Incentives That Reflect Societal Value of Antibiotics.
- Published in:
- Clinical Infectious Diseases, 2021, v. 72, n. 9, p. e420, doi. 10.1093/cid/ciaa092
- By:
- Publication type:
- Article
Trichodysplasia spinulosa: Case reports and review of literature.
- Published in:
- Transplant Infectious Disease, 2020, v. 22, n. 5, p. 1, doi. 10.1111/tid.13342
- By:
- Publication type:
- Article
Emergency Use Authorization of Remdesivir: The Need for a Transparent Distribution Process.
- Published in:
- 2020
- By:
- Publication type:
- journal article
RESTORE-IMI 1: A Multicenter, Randomized, Double-blind Trial Comparing Efficacy and Safety of Imipenem/Relebactam vs Colistin Plus Imipenem in Patients With Imipenem-nonsusceptible Bacterial Infections.
- Published in:
- Clinical Infectious Diseases, 2020, v. 70, n. 9, p. 1799, doi. 10.1093/cid/ciz530
- By:
- Publication type:
- Article
What's Hot in Clinical Infectious Diseases? 2019 IDWeek Summary.
- Published in:
- Open Forum Infectious Diseases, 2020, v. 7, n. 4, p. N.PAG, doi. 10.1093/ofid/ofaa104
- By:
- Publication type:
- Article
Evaluation of Renal Safety Between Imipenem/Relebactam and Colistin Plus Imipenem in Patients With Imipenem-Nonsusceptible Bacterial Infections in the Randomized, Phase 3 RESTORE-IMI 1 Study.
- Published in:
- Open Forum Infectious Diseases, 2020, v. 7, n. 3, p. N.PAG, doi. 10.1093/ofid/ofaa054
- By:
- Publication type:
- Article
BAD BUGS, NO DRUGS 2002–2020: PROGRESS, CHALLENGES, AND CALL TO ACTION.
- Published in:
- Transactions of the American Clinical & Climatological Association, 2020, v. 131, p. 65
- By:
- Publication type:
- Article
Drug Use and Postoperative Mortality Following Valve Surgery for Infective Endocarditis: A Systematic Review and Meta-analysis.
- Published in:
- Clinical Infectious Diseases, 2019, v. 69, n. 7, p. 1120, doi. 10.1093/cid/ciy1064
- By:
- Publication type:
- Article
Screening of donor and candidate prior to solid organ transplantation—Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice.
- Published in:
- Clinical Transplantation, 2019, v. 33, n. 9, p. N.PAG, doi. 10.1111/ctr.13548
- By:
- Publication type:
- Article
Infectious Diseases Society of America's 10 × '20 Initiative (10 New Systemic Antibacterial Agents US Food and Drug Administration Approved by 2020): Is 20 × '20 a Possibility?
- Published in:
- Clinical Infectious Diseases, 2019, v. 69, n. 1, p. 1, doi. 10.1093/cid/ciz089
- By:
- Publication type:
- Article
Good Studies Evaluate the Disease While Great Studies Evaluate the Patient: Development and Application of a Desirability of Outcome Ranking Endpoint for Staphylococcus aureus Bloodstream Infection.
- Published in:
- Clinical Infectious Diseases, 2019, v. 68, n. 10, p. 1691, doi. 10.1093/cid/ciy766
- By:
- Publication type:
- Article
Considerations for Clinical Trials of Staphylococcus aureus Bloodstream Infection in Adults.
- Published in:
- Clinical Infectious Diseases, 2019, v. 68, n. 5, p. 865, doi. 10.1093/cid/ciy774
- By:
- Publication type:
- Article
Effect of Algorithm-Based Therapy vs Usual Care on Clinical Success and Serious Adverse Events in Patients with Staphylococcal Bacteremia: A Randomized Clinical Trial.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Reply to Paul and Leibovici.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Disseminated mucormycosis masquerading as rejection early after orthotopic heart transplantation.
- Published in:
- Transplant Infectious Disease, 2018, v. 20, n. 1, p. 1, doi. 10.1111/tid.12820
- By:
- Publication type:
- Article
Proposed U.S. Funding Cuts Threaten Progress on Antimicrobial Resistance.
- Published in:
- 2017
- By:
- Publication type:
- journal article
White Paper: Developing Antimicrobial Drugs for Resistant Pathogens, Narrow-Spectrum Indications, and Unmet Needs.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Gram-Positive Bacterial Infections: Research Priorities, Accomplishments, and Future Directions of the Antibacterial Resistance Leadership Group.
- Published in:
- Clinical Infectious Diseases, 2017, v. 64, p. S24, doi. 10.1093/cid/ciw827
- By:
- Publication type:
- Article
The Fight Against Multidrug-Resistant Bacteria.
- Published in:
- 2017
- By:
- Publication type:
- journal article
The United Nations and the Urgent Need for Coordinated Global Action in the Fight Against Antimicrobial Resistance.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Safety of Dalbavancin in the Treatment of Skin and Skin Structure Infections: A Pooled Analysis of Randomized, Comparative Studies.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Reply to DiNubile.
- Published in:
- 2015
- By:
- Publication type:
- Letter to the Editor
Editorial Commentary: The Department of Defense Fights the Battle Against Antimicrobial Resistance: Can the United States Win the War?
- Published in:
- 2014
- By:
- Publication type:
- Editorial
Editorial Commentary: Imminent Challenges: Carbapenem-Resistant Enterobacteriaceae in Transplant Recipients and Patients With Hematologic Malignancy.
- Published in:
- Clinical Infectious Diseases, 2014, v. 58, n. 9, p. 1284, doi. 10.1093/cid/ciu056
- By:
- Publication type:
- Article
10 × '20 Progress—Development of New Drugs Active Against Gram-Negative Bacilli: An Update From the Infectious Diseases Society of America.
- Published in:
- Clinical Infectious Diseases, 2013, v. 56, n. 12, p. 1685
- By:
- Publication type:
- Article
Editorial Commentary: Early High-Dose Daptomycin for Methicillin-Resistant Staphylococcus aureus Bloodstream Infections With Elevated Vancomycin Minimum Inhibitory Concentrations: Ready for Prime Time?
- Published in:
- 2013
- By:
- Publication type:
- Opinion
Effect of an Investigational Vaccine for Preventing Staphylococcus aureus Infections After Cardiothoracic Surgery.
- Published in:
- JAMA: Journal of the American Medical Association, 2013, v. 309, n. 13, p. 1368, doi. 10.1001/jama.2013.3010
- By:
- Publication type:
- Article
Effect of an investigational vaccine for preventing Staphylococcus aureus infections after cardiothoracic surgery: a randomized trial.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Antibiotics for Skin Infections.
- Published in:
- 2013
- By:
- Publication type:
- Editorial
Antibiotics for skin infections: new study design and a step toward shorter course therapy.
- Published in:
- 2013
- By:
- Publication type:
- editorial
Daptomycin for Methicillin-Resistant Staphylococcus aureus Bloodstream Infection and Elevated Vancomycin Minimum Inhibitory Concentrations: Has the Time Come?
- Published in:
- 2012
- By:
- Publication type:
- Editorial
Reply to Tillotson, Outterson et al, and Burgess et al.
- Published in:
- 2010
- By:
- Publication type:
- Letter
Challenges in Anti-Infective Development in the Era of Bad Bugs, No Drugs: A Regulatory Perspective Using the Example of Bloodstream Infection as an Indication.
- Published in:
- Clinical Infectious Diseases, 2010, v. 50, p. S4, doi. 10.1086/647937
- By:
- Publication type:
- Article
Antimicrobial Agents for Complicated Skin and Skin-Structure Infections: Justification of Noninferiority Margins in the Absence of Placebo-Controlled Trials.
- Published in:
- Clinical Infectious Diseases, 2009, v. 49, n. 3, p. 383, doi. 10.1086/600296
- By:
- Publication type:
- Article
Community-based outpatient parenteral antimicrobial therapy (CoPAT) for Staphylococcus aureus bacteraemia with or without infective endocarditis: analysis of the randomized trial comparing daptomycin with standard therapy.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2009, v. 63, n. 5, p. 1034, doi. 10.1093/jac/dkp051
- By:
- Publication type:
- Article
Initial Low-Dose Gentamicin for Staphylococcus aureus Bacteremia and Endocarditis Is Nephrotoxic.
- Published in:
- Clinical Infectious Diseases, 2009, v. 48, n. 6, p. 713, doi. 10.1086/597031
- By:
- Publication type:
- Article
Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America.
- Published in:
- Clinical Infectious Diseases, 2009, v. 48, n. 1, p. 1, doi. 10.1086/595011
- By:
- Publication type:
- Article